Clinical Trials Logo

Miscarriage clinical trials

View clinical trials related to Miscarriage.

Filter by:

NCT ID: NCT03940495 Completed - Miscarriage Clinical Trials

Serum Kisspeptin: a Predictive Marker of Miscarriage or Not?

Start date: May 1, 2019
Phase:
Study type: Observational

This is a prospective observational study. Eligible women undergo ART treatment in our centre will be recruited for the study and each woman will only be included in the study once. Informed written consent will be obtained. Blood serum for hCG level is performed 14 days after the embryo transfer i.e. week 4. If the serum hCG level is >10IU/L, the women are considered pregnant and blood will be saved and checked for kisspeptin level, Another blood test is repeated 1 week later i.e. week 5. A transvaginal ultrasound and blood test will be performed 1 week later i.e. week 6 to confirm the fetal viability and the number of gestational sacs and locate the pregnancy. Blood for hCG and kisspeptin levels are checked at weeks, 4, 5 and 6. Ultrasound will be performed at gestational 8 weeks and 11 weeks. They will be referred for antenatal care when the pregnancy is confirmed on-going at 11 weeks. The purpose is to determine whether serum kisspeptin level in women who conceive in IVF is associated with an increased risk in first trimester miscarriage and compare with serum hCG level in the prediction of the first trimester miscarriage.

NCT ID: NCT03921177 Terminated - Preterm Birth Clinical Trials

Micronutrient Supplementation Before and During 1st Pregnancy to Improve Birth Outcomes (JiVitA-5)

JiVitA-5
Start date: January 17, 2019
Phase: N/A
Study type: Interventional

The purpose of this cluster-randomized trial is to evaluate the efficacy of daily, multiple micronutrient (MM) supplement versus identical placebo use among nulligravid, recently married women, starting preconceptionally through the 1st trimester of pregnancy, in reducing low birth weight and other adverse pregnancy outcomes in rural Bangladesh.

NCT ID: NCT03813849 Recruiting - Miscarriage Clinical Trials

Remnants of Conception After Suction Evacuation of Missed Abortion

Start date: June 10, 2016
Phase:
Study type: Observational

All women admitted for surgical evacuation of missed abortion after failure of medical treatment from June 2016 underwent transvaginal sonography immediately after completion of the procedure as judged by the operator to ensure absence of remnants.

NCT ID: NCT03628625 Recruiting - Miscarriage Clinical Trials

Letrozole Pretreatment With Misoprostol fInduction of Abortion In First-Trimester Missed Miscarriage

Start date: September 10, 2018
Phase: Phase 2
Study type: Interventional

This study compares the success rate of letrozole and misoprostol versus misoprostol alone for medical termination of first trimester pregnancy.

NCT ID: NCT03577314 Recruiting - Oral Health Clinical Trials

Is There an Interaction Between Recurrent Miscarriage and Dental Health

Start date: April 15, 2018
Phase:
Study type: Observational

Oral infections can trigger the production of pro-inflammatory mediators that may be risk factors for miscarriage. The investigators investigated whether oral health care patterns that may promote or alleviate oral inflammation were associated with the history of miscarriage in Turkish women.

NCT ID: NCT03487354 Completed - Miscarriage Clinical Trials

Medical Abortion With Single Daily Dose of Misoprostol

Start date: April 1, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

Medical abortion using multiple vs single daily dose of misoprostol in first trimester miscarriage.

NCT ID: NCT03479879 Completed - Miscarriage Clinical Trials

Estradiol Pretreatment With Misoprostol in Second Trimester Miscarriage

Start date: March 21, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

To compare the effectiveness of estradiol pretreatment with misoprostol and vaginal misoprostol alone in induction of second trimestr miscarriage.

NCT ID: NCT03442335 Completed - Miscarriage Clinical Trials

Implantation Test for Endometrial Receptivity

Start date: December 12, 2017
Phase:
Study type: Observational

Background Miscarriage is the most frequent complication of pregnancy and represents the spontaneous loss of the embryo or foetus before it is able to survive independently (24 weeks of gestation). It affects up to 50% of pregnancies with the vast majority (80%) occurring at pre-clinical stage before the woman recognises the pregnancy. Up to 5% of couples suffer recurrent miscarriage defined as 2-3 or more miscarriages leading to physical, emotional and financial consequences for couples, doctors and medical systems. Different maternal health problems (thyroid disease, sticky blood, autoimmune disease, anatomical anomalies of the womb) and embryo defects may be responsible for some of the miscarriages; however, more than 50% of the occurrences have no identifiable cause based on the current diagnostic tests. Aim The aim of the present research proposal is to understand the role of the lining of the womb in miscarriage and to explore the development of a potential implantation test that is cost-effective and may be implemented in clinical practice. Methods Over a period of two years, women who suffered recurrent miscarriage will be approached in the advanced miscarriage clinic at Birmingham Women's Hospital during their routine appointment. Participants will be invited to participate by undergoing chromohysteroscopy and/or a biopsy from the lining of the womb during an outpatient appointment. Chromohysteroscopy is based on a routine hysteroscopy which involves visualising the inside of the womb using a narrow telescope passed through the neck of the womb (cervix). "Chromo" comes from the fact that an iodine based dye will be injected to increase the power of the test. The biopsy will be taken using a narrow plastic tube passed through the cervix. It is a standard diagnostic test for women with abnormal bleeding. As part of the present research, different cells and molecules will be analysed from the biopsy sample.

NCT ID: NCT03395665 Completed - Infertility Clinical Trials

Estradiol, Progesterone and Endometrial Thickness in Frozen Euploid Embryo Transfer

Start date: January 2014
Phase: N/A
Study type: Observational

The development and improvement in Preimplantation genetic diagnosis/screening (PGS) in association with the efficacy and security of vitrification and trophectoderm biopsy, more efficient stimulation schemes and laboratory improvements in culture and embryo selection have contributed to high success of the assisted reproductive technologies(ART). Transferring an euploid embryo avoids one of the main reasons of miscarriage and implantation failure ( Rubio et al, 22016) and overcomes one of the most important confounding factors. Usually, the transfer of euploid embryos is performed under standard hormone replacement therapy (HRT) and are referred to as FET-PGS cycles( Frozen embryo transfer). The study of FET-PGS cycles with the transfer of a single euploid blastocyst is the best model for evaluation of the impact of the endometrial preparation . Among factors influencing FET outcomes, patient's age, endometrial preparation, endometrium thickness, endometrial pattern, number and quality of embryos transferred , difficulty at ET, recently P4 have received more attention . The importance of Progesterone (P4) in embryo implantation has been widely studied. P4 plays an important role in endometrial gland formation, embryonic implantation and pregnancy maintenance, both in natural and artificial cycles.

NCT ID: NCT03354780 Completed - Endometriosis Clinical Trials

Endometriosis and Risk of Miscarriage

Start date: January 15, 2016
Phase: N/A
Study type: Observational

The aim of this study is to compare the rate of miscarriage at first spontaneous pregnancy among women with endometriosis with the rate of miscarriage at first spontaneous pregnancy among women without endometriosis.